160 related articles for article (PubMed ID: 4504846)
1. Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes.
Sjögren HO; Hellström I; Bansal SC; Warner GA; Hellström KE
Int J Cancer; 1972 Mar; 9(2):274-83. PubMed ID: 4504846
[No Abstract] [Full Text] [Related]
2. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.
Hellström I; Sjögren HO; Warner G; Hellström KE
Int J Cancer; 1971 Mar; 7(2):226-37. PubMed ID: 5104167
[No Abstract] [Full Text] [Related]
3. 'Nonspecific' blocking of human ovarian carcinoma-associated cellular cytotoxicity in vitro.
Saksela E; Penttinen K; Pyrhönen S
Scand J Immunol; 1974; 3(6):781-8. PubMed ID: 4376262
[No Abstract] [Full Text] [Related]
4. In vitro study of cellular immunity against autochthonous human cancer.
Segall A; Weiler O; Genin J; Lacour J; Lacour F
Int J Cancer; 1972 Mar; 9(2):417-25. PubMed ID: 4339416
[No Abstract] [Full Text] [Related]
5. Relationship between blocking and unblocking activity and tumor growth in vivo.
Sjögren HO; Bansal SC
Natl Cancer Inst Monogr; 1972 Dec; 35():231-5. PubMed ID: 4349148
[No Abstract] [Full Text] [Related]
6. Evidence for specific tumor cytotoxic antibodies in serum of cervical cancer patients.
Weintraub I; Klisak I; Lagasse LD; Byfield JE
Am J Obstet Gynecol; 1973 Aug; 116(7):985-92. PubMed ID: 4124024
[No Abstract] [Full Text] [Related]
7. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
Bloom ET
Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
[No Abstract] [Full Text] [Related]
8. Demonstration of cell-mediated immunity to human neoplasms of various histological types.
Hellström I; Hellström KE; Sjögren HO; Warner GA
Int J Cancer; 1971 Jan; 7(1):1-16. PubMed ID: 4322937
[No Abstract] [Full Text] [Related]
9. Workshop in human tumor immunology.
Oettgen HF; Bean MA; Klein G
Cancer Res; 1972 Dec; 32(12):2845-53. PubMed ID: 4345410
[No Abstract] [Full Text] [Related]
10. Cell-mediated immune mechanisms of tumor cell destruction.
Perlmann P; O'Toole C; Unsgaard B
Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
[No Abstract] [Full Text] [Related]
11. Active specific immunotherapy of human solid tumors.
Rosato FE
Ann N Y Acad Sci; 1976; 277(00):332-8. PubMed ID: 1069552
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes in human osteosarcoma.
Tsang KY; Singh I; Blakemore WS
J Natl Cancer Inst; 1979 Apr; 62(4):743-8. PubMed ID: 285287
[TBL] [Abstract][Full Text] [Related]
13. Immunological studies of women with primary breast carcinoma.
Jeejeebhoy HF
Int J Cancer; 1975 Jun; 15(6):867-78. PubMed ID: 1150343
[TBL] [Abstract][Full Text] [Related]
14. Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.
Mattes MJ; Cordon-Cardo C; Lewis JL; Old LJ; Lloyd KO
Proc Natl Acad Sci U S A; 1984 Jan; 81(2):568-72. PubMed ID: 6582512
[TBL] [Abstract][Full Text] [Related]
15. Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.
Sjögren HO; Hellström I; Bansal SC; Hellström KE
Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1372-5. PubMed ID: 5288389
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific cellular cytotoxicity to human sarcomas: evidence for a cell-mediated host immune response to a common sarcoma cell-surface antigen.
Cohen AM; Ketcham AS; Morton DL
J Natl Cancer Inst; 1973 Mar; 50(3):585-9. PubMed ID: 4513520
[No Abstract] [Full Text] [Related]
17. A correlation between the expression of CD 8 antigen and specific cytotoxicity of tumor-infiltrating lymphocytes.
Okada Y; Yahata G; Takeuchi S; Seidoh T; Tanaka K
Jpn J Cancer Res; 1989 Mar; 80(3):249-56. PubMed ID: 2524461
[TBL] [Abstract][Full Text] [Related]
18. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.
Mavligit GM; Ambus U; Gutterman JU; Hersh EM; McBride CM
Nat New Biol; 1973 Jun; 243(127):188-90. PubMed ID: 4514633
[No Abstract] [Full Text] [Related]
19. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
Kern DH; Fritze D; Schick PM; Chow N; Pilch YH
J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma.
Perlmann P; O'Toole C; Unsgaard B
Natl Cancer Inst Monogr; 1972 Dec; 35():223-9. PubMed ID: 4540587
[No Abstract] [Full Text] [Related]
[Next] [New Search]
